Radiation Dose Optimization in CT Using Automatic Patient Positioning.

Sponsor
Dr. Panagiota Manava (Other)
Overall Status
Recruiting
CT.gov ID
NCT05135208
Collaborator
(none)
3,600
1
15.9
225.9

Study Details

Study Description

Brief Summary

To evaluate the effect on radiation dose using intelligent camera positioning in comparison to manual positioning by the radiology assistant.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The positioning of the patient at the beginning of every CT examination has an major influence on the image quality and especially on the respective effective patient dose in the CT scan. If the patient position is closer to the X-ray tube, the patient dose increases significantly and if the vertical patient position is chosen too far away from the X-ray tube, the applied dose decreases, but also the image quality.

    In a retrospective observational study, patients were examined on the CT scanner Somatom X.Cite and divided into two groups, one group was with intelligent camera positioning and the other with manual positioning.

    The patients received their CT scan at the Institute Radiology and Nuclear Medicine at the Nuremberg North Hospital strictly according to the clinical indication and without influence of the study.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    3600 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Effect of Automated Patient Positioning in CT Using a 3D Camera on Organ Dose - A Comparison of Manual Positioning by the Radiology Assistant and Intelligent Camera Positioning.
    Actual Study Start Date :
    Feb 1, 2021
    Anticipated Primary Completion Date :
    May 1, 2022
    Anticipated Study Completion Date :
    Jun 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    experimental group

    patients positioned with 3D camera

    control group

    patients positioned by experienced radiology assistants

    Outcome Measures

    Primary Outcome Measures

    1. Effective dose [10 months]

      the absorbed dose to different organs of the body

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Only patients with a clinical indication for a CT Scan

    Exclusion Criteria:

    renal insufficiency, manifest hyperthyroidism and pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Institute of Radiology and Nuclear Medicine Nuremberg Bavaria Germany 90419

    Sponsors and Collaborators

    • Dr. Panagiota Manava

    Investigators

    • Study Director: Michael M. Lell, Prof. Dr., Department of Radiology and Nuclear Medicine, Klinikum Nuernberg, Paracelsus Medical University, Germany

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dr. Panagiota Manava, Dr. med. Panagiota Manava, MD, Attending Radiologist, Principal Invesigator, Paracelsus Medical University
    ClinicalTrials.gov Identifier:
    NCT05135208
    Other Study ID Numbers:
    • CT_2021
    First Posted:
    Nov 26, 2021
    Last Update Posted:
    Apr 28, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Apr 28, 2022